IRIX $2.24 -0.4444%
RTA.PA $46.67 0.3419%
IAAA.L $78.42 -0.1019%
MJ $3.21 -2.1951%
1160.HK $0.45 4.6512%
WTMF $34.24 -0.1938%
JHMB $21.92 0.4353%
VIHAU $10.51 0%
JOJO $14.91 0.5396%
JCAG.L $90.72 -3.71461%
GHLD $10.05 0.9036%
OSH $39.00 0%
GYM.L $101.20 2.6369%
SWN $4.90 3.7076%
ANXG.L $12 102.00 0.3067%
1293.HK $0.35 1.4493%
1069.HK $0.01 0%
CEM $31.71 0.622%
MNDY $129.83 -2.3908%
CWH $25.06 -0.3182%
BFSP.L $87.00 0%
MCO $308.41 -0.1748%
NMMCU $10.00 0%
IMRNW $0.09 0%
1916.HK $0.99 -1%
8506.HK $1.31 0%
0684.HK $1.12 0%
WFCF $14.01 3.1664%
3998.HK $3.62 -0.2755%
HEMO.L $2.23 4.7059%
VTY.L $787.00 1.8111%
ACTG $3.96 -1%
NETE $13.09 0%
SLI $3.52 -1.1208%
CPTN $0.38 -6.3399%
1747.HK $0.65 6.5574%
0633.HK $0.10 0%
CWS $50.50 0.3577%
CFFEU $10.64 0%
ALVOW $1.35 12.5%
USAC.PA $381.52 0.363%
0JOT.L $6.86 0.5114%
0HUZ.L $1.48 14.1538%
PHSP.L $1 770.70 -1.4153%
EDI $5.09 -3.7898%
MCEF $17.29 -0.595573%
0066.HK $38.70 -2.0253%
SSYS $14.17 -2.8464%
TSVT $11.33 -3.82%
ALL $117.94 -0.3296%
ORM.L $0.75 0%
PMAM3.SA $4.10 -0.4854%
INFA.L $18.13 0%
CNOBP $14.40 -1.0439%
CACX.L $6 424.50 0.1949%
THCB $10.00 0%
UAN $84.21 -1.2315%
BMOB3.SA $13.82 -2.6761%
PXMD $1.63 5.7597%
3886.HK $0.30 1.6949%
SUSB $24.12 -0.2894%
OCN.L $900.00 -0.2217%
0IXY.L $85.00 0%
IEM.L $411.00 0.3663%
EMAN.L $66.74 1.1212%
GSQB $10.40 0%
AERC $3.40 17.2414%
ALVAP.PA $9.36 -1.0571%
0N42.L $27.00 0%
SAN.PA $99.30 0.1412%
TFSL $11.14 -0.8897%
XOMA $19.11 3.0189%
ADX $15.53 -0.3312%
XX2D.L $28.04 0.2503%
NEPT $0.22 -0.8636%
SEC.L $309.50 2.1452%
IVCP $10.39 0%
HETA3.SA $96.00 0%
PERK.CN $0.02 0%
SSPY $64.07 -0.2628%
POWI $78.11 -1.3701%
HBCP $30.15 0.9036%
FVT $10.05 0%
CB3.PA $207.21 -0.3338%
BRSR3.SA $11.70 -4.0197%
OCIO $28.83 -0.3178%
DOOO $72.99 -0.2324%
8040.HK $0.56 -3.4483%
0KFH.L $34.79 -2.1761%
LYS.PA $0.28 0%
SHOE.L $242.50 0%
AMCX $13.91 -2.6592%
RAAS $1.19 -2.3115%
PIG.PA $3.39 0.2959%
IAI $86.64 -0.471%
ROOT $5.00 -2.7237%
NCZ $2.92 -1.1864%
NRGV $1.95 -2.505%
ZYT.L $99.00 -1.4925%
0484.HK $0.90 1.1236%
Eng
Логотип
Eng
Лого

Evgen Pharma plc EVG.L

$3.86

-$0.04 (-1.03%)
На 18:02, 12 мая 2023

Ранг: 3

Ранг - это оценка кредитоспособности корпорации.

Ключевые показатели

  • Marketcap

    10445744.00000000

  • week52high

    7.80

  • week52low

    2.83

  • Revenue

    0

  • P/E TTM

    -368

  • Beta

    1.60992300

  • EPS

    -0.01000000

  • Last Dividend

    0.00000000

  • Next Earnings Date

    23 мар 2023 г. в 14:00

Описание компании

Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.

Свежие комментарии

Оставьте свой голос

Анонимное голосование

Будет ли рост российского рынка к концу года?

  • Да

    87%

  • Нет

    12%

Проголосовал 8 человек